TerminatedNot Applicable

Pilot Study for PET/MR Imaging of Covid-19

Stopped: The associated funding source was ended, and the proposed duration of the study ended.

United States3 participantsStarted 2022-07-01

Plain-language summary

The primary goal of this project is to study the feasibility of a prototype brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of metabolism and perfusion in Covid-19 negative and positive/once positive subjects. This study serves as a pilot study for establishing an imaging protocol for combined PET and MR derived functional information as well as MRI acquired anatomical information.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Whole body radiation dose in the last year of less than 5000 mrem determined via subject verbal history reporting
✓. Must be at least 21 years of age
✓. Deemed healthy to endure duration of imaging study as confirmed via study PI
✓. Proof of COVID-19 viral or antibody testing within the timeframe of \>20 days but \<=180 days prior to scan.

Exclusion criteria

✕. History of non-MRI compatible surgeries, implants, or activities
✕. Pregnant or nursing
✕. History of allergic reactions to PET radiotracers (via patient verbal report and /or medical record review.

What they're measuring

Image quality of PET/MR

Timeframe: Up to 24 months

Trial details

NCT IDNCT04954248

SponsorStanford University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-19

View on ClinicalTrials.gov More Brain Diseases trials